General Gastro News Articles
Gastro
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?


Article ID

Home
General Gastro
Messages
Conferences
Jobs
Newsletters
My Library
Topics in
Gastro
        Basic Science/Genetics
        Biliary System/Pancreas
        Colorectal Cancer/Polyps
        Economics of Medicine
        Endoscopy
        Esophagus
        GERD/Stomach
        GI Bleeding
        GI Infectious Disease
        GI Motility
        GI Oncology
        Hepatology
        Inflammatory Bowel Dz
        Obesity
        Parenteral/Ent Nutrition
        Peds Gastroenterology
        Pharmacology/kinetics
        Popular Press
        Radiology/Diagnostics
        Small/Large Intestine
        Transplant
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
Top Ten Searches
esophageal  esophageal
probiotics  probiotics
bile duct  bile duct
hepatotoxicity  hepatotoxicity
dyspepsia  dyspepsia
colonoscopy  colonoscopy
helicobacter  helicobacter
hemochromatosis  hemochromatosis
colitis  colitis
resection  resection
 
Sponsor
MDLinx Email Article

To email this article, enter your own "From Email" address,
the recipient's "To Email" address, and click the "Send Email" button.
You may send to up to 5 email addresses.
*From Email:  
*To Email:  
To Email:  
To Email:  
To Email:  
To Email:  
Synchronous colorectal liver metastases: is it time to reconsider traditional paradigms of management
Reddy SK et al. - In a review of synchronous colorectal liver metastases (CLM), it appears that the traditional treatment paradigm centering on the utility of prehepatectomy chemotherapy for resectable synchronous CLM should be reconsidered. Recent developments underscore the need for prospective randomized controlled trials evaluating the optimal timing of hepatectomy relative to chemotherapy.

Methods
  • Pts with synchronous CLM are typically treated with initial colorectal resection followed by arbitrary and prolonged courses of chemotherapy.
  • Partial hepatectomy is considered only for pts without interval disease progression.
  • This review describes the rationale for this treatment approach and recent developments suggesting that this management paradigm should be reconsidered.

Results
  • Because asymptomatic colorectal cancer often does not lead to complications, and given the potential benefit of chemotherapy in downsizing unresectable to resectable liver disease, most pts with asymptomatic primary tumors and unresectable synchronous CLM should be first treated with chemotherapy.
  • Initial hepatic resection should be considered for resectable synchronous CLM.
  • Survival benefits from prehepatectomy chemotherapy have not been established.
  • Several reports demonstrate morbidity after hepatic resection from extended durations of irinotecan- and/or oxaliplatin-based prehepatectomy chemotherapy.
  • Although shorter treatment periods may not have these deleterious effects on subsequent hepatic resection, prospective studies reveal that most pts with supposedly aggressive disease with short treatment durations will not be identified.
  • Complete radiologic response to prehepatectomy chemotherapy is not only rare but also does not equate with a complete pathological response.
  • Several studies suggest that simultaneous colorectal and minor hepatic resections can performed safely with benefits in total morbidity when compared with traditional staged procedures.
[more...]
Sponsor

Read a Different Specialty

Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pain
Pediatrics
Practice Management
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Gastroenterology Profession Index

Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2009 MDLinx, Inc.